RIPK2 induces docetaxel resistance in prostate cancer through the NF-κB/P-gp signaling pathway

• Shaoqiang Xing ,

  Contributed equally to this work with: Shaoqiang Xing, Zhaoliang Xu

  Roles Investigation, Methodology, Software, Writing – original draft

  Affiliations The First Central Clinical School, Tianjin Medical University, Tianjin, China, Department of Urology, Tianjin First Central Hospital, Tianjin, China

  ⨯
• Zhaoliang Xu ,

  Contributed equally to this work with: Shaoqiang Xing, Zhaoliang Xu

  Roles Formal analysis, Investigation, Methodology, Project administration

  Affiliations The First Central Clinical School, Tianjin Medical University, Tianjin, China, Department of Urology, Tianjin First Central Hospital, Tianjin, China

  ⨯
• Sheng Zeng,

  Roles Investigation, Methodology, Visualization

  Affiliation Department of Urology, Tianjin First Central Hospital, Tianjin, China

  ⨯
• Minghao Yue,

  Roles Investigation, Methodology, Validation

  Affiliation Department of Urology, Tianjin First Central Hospital, Tianjin, China

  ⨯
• Wenzhou Xing,

  Roles Investigation, Methodology

  Affiliation Department of Urology, Tianjin First Central Hospital, Tianjin, China

  ⨯
• Qian Liu

  Roles Funding acquisition, Supervision, Writing – review & editing

  * E-mail: simonlq1971@126.com

  Affiliations The First Central Clinical School, Tianjin Medical University, Tianjin, China, Department of Urology, Tianjin First Central Hospital, Tianjin, China

  https://orcid.org/0009-0006-4743-4713

  ⨯